Florida Pharmacy Shut Down as Public Health Menace
Published Date: 1/23/2025
Notice
Summary
Xubex Community Pharmacy in Florida lost its DEA registration because it was seen as a danger to public health. The pharmacy didn’t ask for a hearing to defend itself, so the suspension became final. This means Xubex can’t legally handle controlled substances anymore, effective immediately, impacting their business and customers.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Revokes Xubex Pharmacy Registration
The DEA revoked Xubex Community Pharmacy's Certificate of Registration No. FX3643081 and denied any pending applications for renewal, modification, or additional registration in Florida. The final Order revocation is effective February 24, 2025, after an earlier OSC/ISO and immediate suspension issued May 29, 2024.
Customers Lose Access to Controlled Drugs
Because Xubex Community Pharmacy can no longer handle controlled substances, customers who got controlled drugs there can no longer obtain them from that pharmacy. The Agency found that on November 30, 2023 Xubex dispensed ten oxycodone tablets for $260 without a prescription and on December 19, 2023 it dispensed two hydromorphone tablets for $50; the pharmacy did not request a hearing and the revocation is effective February 24, 2025.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in